This award is for projects undertaken in mental health by foundation trainee pharmacists.
The award includes attendance at the CMHP annual conference, held each autumn, with all accommodation and reasonable travel costs included, and two years’ CMHP membership. The award will be made to a winner and runner up. In addition, the winner will receive a prize award of £100.
This is a long-standing award, having been first launched in 2002.
The 2024 call opens on 28 March. Closing date for applications: 28 June 2024
Criteria
To be eligible for this award, your project must have been undertaken during your foundation training: this may either be as part of an undergraduate sandwich course or as part of postgraduate training. The project could be undertaken in any sector of pharmacy, including community, hospital, academia and industry.
Your project must be wholly or mainly about a subject related to the practice of mental health pharmacy. It is anticipated that most projects undertaken by foundation trainee pharmacists will be as part of an audit cycle, a literature search and evaluation as part of service development or a service evaluation, although applications need not be limited to such projects.
The work must have been undertaken wholly by you, the applicant; although the project may have been supervised.
To apply, you must have undertaken foundation training in the year leading up to the call for applications.
You must be willing to present your project as a poster at our Annual international conference, and we expect to share winning and runner-up abstracts with the wider membership.
Process of application
Please pay attention to the requirements when constructing your report and take care to complete all sections.
For your application to be considered, reports must be provided with a covering letter that states all the following in order:
- The full title of your project
- Your details
- full name
- home or work address (that will be valid after 1st September)
- correspondence email address (that will be valid after 1st September)
- telephone/mobile number
- The address(es) of the establishment(s) where the project was undertaken/where the data were collected
- The name, address and email address of the supervisor or tutor for the project and all other co-applicants as appropriate
- A statement confirming that you undertook the work yourself without assistance other than that of a supervisor or tutor
- A statement acknowledging that you are willing to present your project as a poster at the CMHP Annual Conference.
- A signed and dated declaration from your supervisor or tutor that the report is of publication standard and quality.
We recommend you use the report structure and sub-headings described below and we ask that the overall 1500 word count is not exceeded – this includes the 350 word count for the abstract.
The abstract and then subsequent report should be included that follows the IMRAD format (Introduction, Method, Results and Discussion). You should also reference your report accordingly using Vancouver style referencing.
The abstract should summarise the study, so as to be comprehensible by an external reader. It should identify key findings, include actual numerical data from findings (if appropriate) and draws insightful implications of the research.
Before submitting your abstract, please read the Guidelines for project award abstract submissions 2024.
Submitting Your Abstract
Please submit your application by email to [email protected] by the deadline of 28 June 2024.
Judging
A panel of judges will consider the applications anonymously.
The decision of the judges is final; no communications will be entered into.
The award
An award will be made to a winner and runner up. The winner and runner-up will be notified in writing by the 1st September. The award will enable attendance at the CMHP Annual Psychiatric Pharmacy Conference, where the award will be made. All accommodation and reasonable travel costs will be funded as part of the bursary, and two years’ CMHP membership will also be provided.
This award is funded by the CMHP.
Previous winners
2023: Ka Lam (Karen) Leong, East London NHS Foundation Trust: An Audit Report on Baseline Physical Health Monitoring of High-dose Antipsychotics Therapy in Luton and Bedfordshire Inpatient Mental Health Setting
2022: Not awarded
Before 2022, the award was known as the Pre-registration Pharmacist Project Award:
2021: Ninoslav Majkic, Cwm Taf Morgannwg Health Board: Audit of Medical reviews of selective serotonin reuptake inhibitors in GP Practice
2020: Not offered
2019: Anisha Patel, Central and North West London NHS Foundation Trust: The review of benzodiazepine prescribing upon discharge
2018: Not awarded
2017: Clare Geoghegan, Worthing Hospital, Western Sussex Hospitals NHS Foundation Trust: Audit of Documentation of Clozapine in GP records
2016: Shabnam Sobhdam, Central and North West London NHS Foundation Trust: An audit of the number and type of dispensing errors that are identified at the final checking stage in the dispensary at St Charles’ Hospital.
2015: Heather Axford: A clinical audit of the documentation of medicines reconciliation on admission to York-based Mental Health Inpatient Beds
2014: Zahra Javadi: An audit of Rapid Tranquilisation use within Central and North West London (CNWL) NHS Foundation Trust
2013 Kristina Sakenyte: Reported medication errors in MH crisis resolution and home treatment teams
2012: Eleanor Bevan, Heart of England Foundation Trust - An audit on the adherence to the new recommendation for the use of citalopram.
2011: Lorna Hand, Sherwood Forest Hospitals - An audit of clozapine use in assertive outreach teams.
2010: Jacqueline Payne - Do assertive outreach patients with schizophrenia receive adequate cardiovascular risk monitoring as per NICE Guidance?
2009 Joint winners: Helen Frances Wade - The Off-label use of psychotropic’s for unlicensed indications in Adult Inpatients, and Louise Millen - A clinical audit of the use of antipsychotics in the management of BPSD
2007: Mohammed Miah, Newham Centre for Mental Health NHS Trust - An audit on usage of benzodiazepines.